| P2093 | author name string | H D Banta | |
| P2860 | cites work | Measuring quality of life in clinical trials: a taxonomy and review | Q34104608 |
| | Assessment of quality of life in cardiovascular therapy | Q34446807 |
| | Measuring the effectiveness of heart transplant programmes: quality of life data and their relationship to survival analysis | Q36446221 |
| | A perspective on the role of quality-of-life assessment in clinical trials | Q39361194 |
| | Measuring the quality of life of cancer patients: psychometric properties of instruments | Q39549623 |
| | Quality of life: does measurement help? | Q41302160 |
| | Auranofin therapy and quality of life in patients with rheumatoid arthritis. Results of a multicenter trial | Q41451581 |
| | The effects of antihypertensive therapy on the quality of life | Q43484013 |
| | Evaluation of quality of life in clinical trials. Selecting quality-of-life measures | Q44218283 |
| | Efficacy and cost effectiveness of adjuvant chemotherapy in women with node-negative breast cancer. A decision-analysis model | Q44942727 |
| | Methodologic challenges in the development of utility measures of health-related quality of life in rheumatoid arthritis | Q45093834 |
| | Association between recombinant human erythropoietin and quality of life and exercise capacity of patients receiving haemodialysis. Canadian Erythropoietin Study Group | Q67282301 |
| | Cost effectiveness of prophylactic intravenous immune globulin in chronic lymphocytic leukemia | Q67990565 |
| | The hierarchy of quality-of-life assessment, the Health Assessment Questionnaire (HAQ), and issues mandating development of a toxicity index | Q68271815 |
| | The use of generic and specific quality-of-life measures in hemodialysis patients treated with erythropoietin. The Canadian Erythropoietin Study Group | Q68271824 |
| | The quality of life of hemodialysis recipients treated with recombinant human erythropoietin. Cooperative Multicenter EPO Clinical Trial Group | Q68926213 |
| | Biotechnology--the enormous cost of success | Q70139868 |
| | Measuring the quality of life of cancer patients: the Functional Living Index-Cancer: development and validation | Q70356145 |
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 45-49 | |
| P577 | publication date | 1993-04-01 | |
| P1433 | published in | International Journal of Clinical Pharmacy | Q15759467 |
| P1476 | title | Quality of life. 1. Perspectives | |
| P478 | volume | 15 | |